Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0041-2013Class II

IDS-iSYS Ostase BAP (Bone Alkaline Phosphatase) Control Set, Catalog Number IS-2830. Packaged in cardboard...

Immunodiagnostic Systems Ltd. / initiated 2012-08-10 / Terminated / root cause: labeling and UDI

Immunodiagnostics Systems Ltd began a recall of IDS-iSYS Ostase BAP (Bone Alkaline Phosphatase) Control Set, Catalog Number IS-2830. Packaged in cardboard Box containing plastic bottles. The IDS-iSYS Ostase... on . FDA classified it as Class II and gives the reason as "It has been noted by staff at IDS Inc. that stock of the affected products held at IDS Inc. are labeled with IVD labels although they are not registered for sale as IVDs in the United States. The products should have...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0041-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Immunodiagnostic Systems Ltd.
Product
IDS-iSYS Ostase BAP (Bone Alkaline Phosphatase) Control Set, Catalog Number IS-2830. Packaged in cardboard Box containing plastic bottles. The IDS-iSYS Ostase BAP (IDS-iSYS BAP) Control Set is used for quality control of the IDS-iSYS Ostase BAP (Bone Alkaline Phosphatase) Assay on the IDS-iSYS Multi-Discipline Automated Analyser.
Product code
CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes
Reason for recall
It has been noted by staff at IDS Inc. that stock of the affected products held at IDS Inc. are labeled with IVD labels although they are not registered for sale as IVDs in the United States. The products should have been labeled as Research Use Only or Investigational use only dependent on their usage.
Root cause tag
labeling and UDI
FDA root cause
Labeling False and Misleading
Action
Immunodiagnostics Systems sent Customer notification letters via email and notified customers of the recall. The notification included the reason for recall, product information with codes, lot number, manufacturing/distribution date, and exp date. The notification included instructions to customers: Actions to be taken by the customer: Customers should complete the attached Recall and Acknowledgement Form and take the following actions: 1) Check your stock for the products included within the scope of the recall. Cease use and distribution and quarantine all affected product lots immediately. 2) Complete the enclosed Recall & Acknowledgement Form and immediately fax back to Immunodiagnostic Systems. This will allow us to document your receipt of this letter and the amount of product you have on hand for return. 3) Return any affected product freight collect, along with the original completed Recall & Acknowledgement Form to your local IDS office. Contact information was also provided. For questions regarding this recall call +44 (191) 5195212.
Quantity in commerce
3
Distribution
Nationwide Distribution including NY, CA, ME and CT.
Product codes and lots
Lot 1177, EXP Aug 2012

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0041-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0039-2013Class IITerminatedVoluntary: Firm initiated
Z-0040-2013Class IITerminatedVoluntary: Firm initiated
Z-0041-2013Class IITerminatedVoluntary: Firm initiated
Z-0042-2013Class IITerminatedVoluntary: Firm initiated
Z-0043-2013Class IITerminatedVoluntary: Firm initiated
Z-0044-2013Class IITerminatedVoluntary: Firm initiated
Z-0045-2013Class IITerminatedVoluntary: Firm initiated